Literature DB >> 10027346

Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study.

C A Stiller1, S Benjamin, R A Cartwright, J V Clough, D W Gorst, M E Kroll, J R Ross, K Wheatley, J A Whittaker, P R Taylor, S J Proctor.   

Abstract

We report a population-based study of patterns of care and survival for people with acute leukaemia diagnosed at age 15-29 years during 1984-94 in regions of England and Wales covered by specialist leukaemia registries. There were 879 patients: 417 with acute lymphoblastic leukaemia (ALL) and 462 with acute myeloid leukaemia (AML). For ALL, actuarial survival rates were 43% at 5 years after diagnosis and 37% at 10 years. Survival improved significantly between 1984-88 and 1989-94 for those aged 15-19 at diagnosis. Patients entered in national clinical trials and those not entered had similar survival rates. Survival rates were similar at teaching and non-teaching hospitals and at hospitals treating different numbers of study patients per year. For AML, survival rates were 42% at 5 years after diagnosis and 39% at 10 years. Survival improved significantly between 1984-88 and 1989-94. Patients entered in the Medical Research Council AML10 trial had a higher survival rate than those who were in the earlier AML9 trial. Survival did not vary with category of hospital. We conclude that survival has improved for adolescents and young adults with acute leukaemia but that there is at present no evidence that centralized treatment results in a survival benefit for patients in this age group.

Entities:  

Mesh:

Year:  1999        PMID: 10027346      PMCID: PMC2362441          DOI: 10.1038/sj.bjc.6690104

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties.

Authors:  J M Chessells; E Hall; H G Prentice; J Durrant; C C Bailey; S M Richards
Journal:  Leukemia       Date:  1998-04       Impact factor: 11.528

Review 2.  Acute lymphoblastic leukaemia in adults: the case for a strategic shift in study approach.

Authors:  S J Proctor
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

3.  Acute lymphoblastic leukaemia in adults in the northern region of England--a study of 75 cases.

Authors:  S J Proctor; P Taylor; R B Thompson; R Finney; M M Reid; P J Hamilton; P Saunders; B Fail; A Dickinson; B Paul
Journal:  Q J Med       Date:  1985-11

4.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Authors:  R P Warrell; S R Frankel; W H Miller; D A Scheinberg; L M Itri; W N Hittelman; R Vyas; M Andreeff; A Tafuri; A Jakubowski
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

5.  Population based survival rates for childhood cancer in Britain, 1980-91.

Authors:  C A Stiller
Journal:  BMJ       Date:  1994-12-17

6.  Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

Authors:  C A Stiller; E M Eatock
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

7.  Evaluation of the impact of allogenic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15-55 years. The Northern Regional Haematology Group.

Authors:  S J Proctor; P R Taylor; A Stark; P J Carey; N Bown; P J Hamilton; M M Reid
Journal:  Leukemia       Date:  1995-07       Impact factor: 11.528

8.  Establishing cancer units.

Authors:  R A Haward
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

9.  Centralised treatment, entry to trials and survival.

Authors:  C A Stiller
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

10.  Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study.

Authors:  J H Youngson; J M Jones; J G Chang; M Harris; S S Banergee
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more
  15 in total

1.  Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults.

Authors:  R S Go; A C Bartley; A Al-Kali; N D Shah; E B Habermann
Journal:  Leukemia       Date:  2015-08-26       Impact factor: 11.528

Review 2.  Long-term complications in adolescent and young adult leukemia survivors.

Authors:  K Scott Baker; Karen L Syrjala
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  From evidence to clinical practice in blood and marrow transplantation.

Authors:  Nandita Khera
Journal:  Blood Rev       Date:  2015-04-19       Impact factor: 8.250

4.  Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.

Authors:  Nandita Khera; Navneet S Majhail; Ruta Brazauskas; Zhiwei Wang; Naya He; Mahmoud D Aljurf; Görgün Akpek; Yoshiko Atsuta; Sara Beattie; Christopher N Bredeson; Linda J Burns; Jignesh D Dalal; César O Freytes; Vikas Gupta; Yoshihiro Inamoto; Hillard M Lazarus; Charles F LeMaistre; Amir Steinberg; David Szwajcer; John R Wingard; Baldeep Wirk; William A Wood; Steven Joffe; Theresa E Hahn; Fausto R Loberiza; Claudio Anasetti; Mary M Horowitz; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-11       Impact factor: 5.742

Review 5.  Acute myelogenous leukemia in adolescents and young adults.

Authors:  Ursula Creutzig; Matthew A Kutny; Ronald Barr; Richard F Schlenk; Raul C Ribeiro
Journal:  Pediatr Blood Cancer       Date:  2018-04-18       Impact factor: 3.167

Review 6.  Is cancer care best at high-volume providers?

Authors:  B E Hillner
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

7.  Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.

Authors:  Motohiro Kato; Atsushi Manabe; Katsuyoshi Koh; Takeshi Inukai; Nobutaka Kiyokawa; Takashi Fukushima; Hiroaki Goto; Daisuke Hasegawa; Chitose Ogawa; Kazutoshi Koike; Setsuo Ota; Yasushi Noguchi; Akira Kikuchi; Masahiro Tsuchida; Akira Ohara
Journal:  Int J Hematol       Date:  2014-06-18       Impact factor: 2.490

8.  Characteristics of advanced cancer patients with cancer-related fatigue enrolled in clinical trials and patients referred to outpatient palliative care clinics.

Authors:  Sriram Yennurajalingam; Jung Hun Kang; Huai Yong Cheng; Gary B Chisholm; Jung Hye Kwon; Shana L Palla; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-08-20       Impact factor: 3.612

9.  Early deaths from childhood cancer. A report from the Childhood Cancer Registry of Piedmont, Italy, 1967-1998.

Authors:  Guido Pastore; Silvia Viscomi; Maria Luisa Mosso; Milena Maria Maule; Benedetto Terracini; Corrado Magnani; Franco Merletti
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

10.  Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

Authors:  Joseph M Unger; William E Barlow; Diane P Martin; Scott D Ramsey; Michael Leblanc; Ruth Etzioni; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.